Toso

Alentis Appoints Alberto Toso Chief Scientific Officer

Retrieved on: 
Monday, April 29, 2024
Oncology, Health, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Management, Cancer, Nature, CLDN1, ETH, Doctor of Philosophy, Roche, Toso, Prostate cancer, Pembrolizumab, CSO, IO, Multimedia, Head, Drug development, Cell Reports, Spacecraft, Pharmaceutical industry

Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective immediately.

Key Points: 
  • Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for organ fibrosis and Claudin-1 positive tumors, announced today that Dr. Alberto Toso has been appointed as Chief Scientific Officer effective immediately.
  • Alberto joined Alentis in 2021 as Head of Oncology.
  • View the full release here: https://www.businesswire.com/news/home/20240429009341/en/
    Alberto Toso, Chief Scientific Officer of Alentis Therapeutics (Photo: Alentis Therapeutics)
    “Alberto has been instrumental in rapidly advancing and expanding our oncology pipeline,” said Roberto Iacone, Chief Executive Officer of Alentis.
  • As a postdoc at the Institute of Oncology Research in Bellinzona, Switzerland, Alberto developed and characterized mouse models for prostate cancer.

Portland Cement Association Elects 2023 Board of Directors Leadership

Retrieved on: 
Wednesday, December 7, 2022
Carbon, Henley, Executive, Infrastructure Sustainability Council of Australia, Council, Partnership, Toso, Roadmap, Safety, Carbon neutrality, Graham Loomes, Knowledge, Filiberto, PCA, Portland Cement Association, Education, Concrete, White House, Research, History, White, Primary energy, Attention, Policy, Management, Renewable energy, Cement

Washington, DC, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Portland Cement Association (PCA) is proud to announce new leadership for its Board of Directors after holding elections yesterday at its Fall Board meeting.

Key Points: 
  • Washington, DC, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Portland Cement Association (PCA) is proud to announce new leadership for its Board of Directors after holding elections yesterday at its Fall Board meeting.
  • “The Portland Cement Association plays a crucial role in the advancement of the cement and construction industries, not only in the U.S., but in partnership with other like-minded organizations around the world,” said Chairman Ruiz.
  • Also at yesterday’s meeting, it was announced that David Loomes is the latest industry executive to join the PCA Board.
  • PCA supports sustainability, innovation, and safety while fostering continuous improvement in cement manufacturing, distribution, infrastructure, and economic growth.